Global Pharmaceutical Gelatin Market Size By Type, By Application, By Source, By Geographic Scope And Forecast

Pharmaceutical Gelatin Market Size And Forecast

Pharmaceutical Gelatin Market size was valued at USD 1.25 Billion in 2023 and is projected to reach USD 1.85 Billion by 2030, growing at a CAGR of 5.5% during the forecast period 2024-2030.

The Pharmaceutical Gelatin Market refers to the global industry segment comprising the production, distribution, and consumption of gelatin specifically used in pharmaceutical applications. Pharmaceutical gelatin serves as a critical ingredient in the formulation of various pharmaceutical products, including capsules, tablets, coatings, and other dosage forms. It is valued for its unique properties such as gelling, stabilizing, and thickening, which are essential for maintaining the integrity and efficacy of pharmaceutical formulations.

Global Pharmaceutical Gelatin Market Drivers

The market drivers for the Pharmaceutical Gelatin Market can be influenced by various factors. These may include

• Growing Need for Softgel and Capsule Formulations The need for pharmaceutical gelatin, a crucial component of their formulation, is being driven by the increased preference for capsules and softgel capsules as dosage forms because of their convenience of consumption, improved bioavailability, and precise dosing.
• Growing Pharmaceutical sector The need for pharmaceutical gelatin is being driven by the growing pharmaceutical sector, especially in emerging nations. The need for gelatin in a variety of applications, including drug delivery systems, coatings, and the production of pharmaceutical products, is anticipated to increase as the pharmaceutical industry continues to expand.
• Technological Developments in Gelatin Production The quality and usefulness of pharmaceutical gelatin are being improved by developments in the production processes for gelatin, such as enhanced extraction and purification procedures. Gelatin is becoming more and more popular among pharmaceutical producers, which is propelling the market’s expansion.
• Growing Prevalence of Chronic Illnesses As the number of chronic illnesses, including cancer, diabetes, and cardiovascular disorders, rises, there is an increasing need for pharmaceutical products, particularly formulations containing gelatin to deliver drugs. In the upcoming years, it is anticipated that this tendency would increase demand for pharmaceutical gelatin even more.
• Expanding Nutraceutical business Pharmaceutical gelatin producers are seeing opportunities as a result of the growing nutraceutical business, which is being propelled by rising consumer awareness of health and wellness. Gelatin plays a major role in the growth of the nutraceuticals market by being utilized extensively in the manufacturing of functional foods and dietary supplements.
• Regulatory Support and Quality Standards Manufacturers are being encouraged to employ premium components, such as pharmaceutical-grade gelatin, by strict laws pertaining to the safety and quality of pharmaceutical products. Pharmaceutical gelatin demand is driven by the need for market participants to adhere to regulatory standards in order to assure product efficacy and consumer safety.
• Growing Research and Development Expenditures Pharmaceutical businesses are anticipated to boost demand for pharmaceutical gelatin by investing more in R&D to create novel medication formulations and delivery techniques. Due to its adaptability and compatibility with a wide range of active components, gelatin is a preferred option for medication development, which propels market expansion.

Global Pharmaceutical Gelatin Market Restraints

Several factors can act as restraints or challenges for the Pharmaceutical Gelatin Market. These may include

• Concerns Regarding Animal-derived Gelatin Pharmaceutical gelatin is primarily derived from animal sources such as bovine or porcine skin and bones. However, there are growing concerns regarding the use of animal-derived ingredients in pharmaceutical products due to cultural, religious, and ethical reasons. This can hinder market growth as consumers and regulatory authorities seek alternative sources or substitutes for gelatin.
• Availability of Alternatives The availability of alternative excipients and formulation ingredients, such as plant-based or synthetic polymers, poses a challenge to the pharmaceutical gelatin market. Manufacturers may opt for these alternatives to cater to consumer preferences for vegetarian or vegan products or to overcome concerns related to animal-derived ingredients, thereby limiting the demand for pharmaceutical gelatin.
• Price Volatility of Raw Materials Fluctuations in the prices of raw materials used in gelatin production, such as animal hides, bones, and skins, can impact the overall production cost of pharmaceutical gelatin. Price volatility may arise due to factors such as changes in supply and demand dynamics, environmental conditions affecting livestock, and geopolitical factors affecting trade. This instability can affect profit margins and hinder market growth.
• Stringent Regulatory Requirements Pharmaceutical gelatin manufacturers must comply with stringent regulatory requirements related to product quality, safety, and traceability. Meeting these regulations entails significant investments in quality control measures, documentation, and adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to regulatory penalties, product recalls, and damage to brand reputation, acting as a restraint on market growth.
• Allergen Concerns Gelatin allergies are relatively rare but can occur in sensitive individuals, leading to adverse reactions upon consumption of gelatin-containing pharmaceutical products. Allergen concerns pose a risk to patient safety and may influence consumer purchasing decisions, particularly among individuals with known allergies or those seeking alternative dosage forms. This factor can limit the adoption of pharmaceutical gelatin in certain patient populations.
• Environmental and Sustainability Issues The production of pharmaceutical gelatin from animal-derived sources raises environmental and sustainability concerns related to land use, water consumption, and greenhouse gas emissions associated with livestock farming. Additionally, waste management issues related to the disposal of gelatin by-products may attract regulatory scrutiny and public attention, impacting market growth.
• Fragmented Market and Intense Competition The pharmaceutical gelatin market is characterized by the presence of numerous regional and global players, leading to intense competition. Market fragmentation can result in pricing pressures, reduced profit margins, and challenges in market penetration and expansion. Moreover, the presence of established players with strong brand recognition and distribution networks can pose barriers to entry for new entrants, further restraining market growth.

Global Pharmaceutical Gelatin Market Segmentation Analysis

The Global Pharmaceutical Gelatin Market is Segmented on the basis of Type, Application, Source, and Geography.

Pharmaceutical Gelatin Market, By Type

• Type A Gelatin Derived from acid-treated collagen, Type A gelatin has an isoelectric point between pH 7 and 9.
• Type B Gelatin Produced by alkaline treatment of collagen, Type B gelatin has an isoelectric point between pH 4.7 and 5.3.

Pharmaceutical Gelatin Market, By Application

• Capsules and Softgel Capsules Gelatin is widely used as a primary ingredient in the production of hard capsules and softgel capsules for oral drug delivery.
• Coatings Gelatin coatings are applied to pharmaceutical tablets and capsules for protection, masking taste, and facilitating swallowing.
• Parenteral Formulations Gelatin is utilized in parenteral formulations such as microencapsulation and microsphere technology for controlled drug release.
• Other Applications Gelatin finds applications in other pharmaceutical formulations such as gels, creams, ointments, and suppositories.

Pharmaceutical Gelatin Market, By Source

• Bovine Gelatin Derived from bovine collagen obtained from cattle hides and bones, bovine gelatin is widely used in pharmaceutical applications.
• Porcine Gelatin Obtained from porcine collagen sourced from pigskin and bones, porcine gelatin is another common type used in pharmaceutical formulations.
• Other Sources Gelatin can also be sourced from alternative sources such as fish (marine) gelatin or plant-based sources for vegetarian or vegan formulations.

Pharmaceutical Gelatin Market, By Geography

• North AmericaMarket conditions and demand in the United States, Canada, and Mexico.
• EuropeAnalysis of the Pharmaceutical Gelatin Market in European countries.
• Asia-PacificFocusing on countries like China, India, Japan, South Korea, and others.
• Middle East and AfricaExamining market dynamics in the Middle East and African regions.
• Latin AmericaCovering market trends and developments in countries across Latin America.

Key Players

The major players in the Pharmaceutical Gelatin Market are

• Nitta Gelatin
• PB Leiner GmbH
• Tessenderlo Group
• Weishardt Holding GmbH & Co. KG
• Gelita AG
• LAPI Gelatine S.p.A.
• NiOx Gelatin
• Croda International Plc
• Eastman Chemical Company
• Rousselot (ADM)
• I gelatina SA
• Gelnex Pharmaceuticals
• Bio-Gelatin GmbH
• Gelatin Kelco Co.

Report Scope

Conclusion

The Pharmaceutical Gelatin Market is poised for substantial growth in the foreseeable future. Factors such as the rising demand for pharmaceutical products, increasing investments in drug development and manufacturing, and the expanding pharmaceutical industry in emerging economies are driving the market expansion. Moreover, advancements in gelatin manufacturing technology, along with the growing trend of using natural and sustainable ingredients in pharmaceutical formulations, are anticipated to further propel market growth. However, challenges such as stringent regulatory requirements and the availability of alternatives may pose constraints to market progression. Nonetheless, strategic collaborations, product innovations, and expanding product portfolios by key market players are expected to create lucrative opportunities for market players in the pharmaceutical gelatin industry.

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any  please connect with our sales team, who will ensure that your requirements are met.